BarshopNJ,SirlinCB,SchwimmerJB,LavineJE, 2008.Review article: epidemiology, pathogenesis and potential treatments of paediatric nonalcoholic fatty liver disease,Aliment Pharmacol Ther 28 13 -24
FanJG,FarrellGC, 2009.Epidemiology of non-alcoholic fatty liver disease in China,J Hepatol 50 204 -210
AmarapurkarDN,HashimotoE,LesmanaLA,SollanoJD,ChenPJ,GohKL, 2007.How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? J Gastroenterol Hepatol, 22 788 -793
FracanzaniAL,ValentiL,BugianesiE,AndreolettiM,ColliA,VanniE, 2008.Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase Levels: A role for insulin resistance and diabetes,Hepatology 48 792 -798
Neuschwander-TetriBA,CaldwellSH, 2003.Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference, 37 1202 -1219
MarchesiniG,BriziM,BianchiG,TomassettiS,BugianesiE, 2001.Nonalcoholic fatty liver disease: a feature of the metabolic syndrome,Diabetes 50 1844 -1850
MarchesiniG,BugianesiE,ForlaniG,CerrelliF,LenziM, 2003.Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome,Hepatology 37 917 -923
YooTW,SungKC,ShinHS,KimBJ,KimBS, 2005.Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome,Circ J 69 928 -933
HjortnaesJ,AlgraA,OlijhoekJ,HuismanM,JacobsJ,ChoiHK,FordES, 2007.Prevalence of the metabolic syndrome in individuals with hyperuricemia,Am J Med 120 442 -447
2018.,Accepted: 3 October -
LiY,XuC,YuC, 2009.Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study,J Hepatol 50 1029 -34
HaqA,MahmoodR,AhmadZ,RehmanJ,JilaniG, 2010.Association of serum uric acid with blood urea and serum creatinine,Pak J Physiol 6 -
SafiAJ,MahmoodR,KhanMA,Haq, 2004.AU.Association of Serum Uric Acid with type 2 Diabetes Mellitus,J Pak Med Ins. -
HaydenMR,TyagiSC, 2004.Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle,Nutr Metab (Lond) 1 10 -
Harrison R,BerryCE,HareJM,BaskolG,BaskolM,KocerD, 2007.Oxidative stress and antioxidant defenses in serum of patients with non-alcoholic steatohepatitis,Clin Biochem 40 776 -780
De OliveiraEP,BuriniRC, 2012.High plasma uric acid concentration: causes and consequences,Diabetol Metab Syndr 4 12 -
PettaS,CammaC,CabibiD,Di MarcoV,CraxiA, 2011.Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease,Aliment Pharmacol Ther 34 757 -766
KonoH,ChenCJ,OntiverosF,RockKL, 2010.Uric acid promotes an acute inflammatory response to sterile cell death in mice,J Clin Invest 120 1939 -1949
HoqueR,VodovotzY,MehalW, 2013.Therapeutic strategies in inflammasome mediated diseases of the liver,J Hepatol 58 1047 -1052
Shi Y, 2010.Caught red-handed: uric acid is an agent of inflammation,J Clin Invest 120 1809 -1811
MarangellaM., 2005.Uric acid elimination in the urine, -
.Pathophysiological implications,Contrib Nephrol 147 132 -48
BaldwinW,McRaeS,MarekG, 2011.Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome,Diabetes 60 1258 -69
SautinYY,NakagawaT,ZharikovS,KangDH,HanL,OuyangX, 2005.Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter,Am J Nephrol 25 425 -33
KanellisJ,WatanabeS,LiJH, 2003.Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2, 41 1287 -93
DasarathyS,DasarathyJ,KhiyamiA, 2009.Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study,J Hepatol 51 1061 -7
LanaspaMA,TapiaE,SotoV, 2011.Uric acid and fructose: potential biological mechanisms,Semin Nephrol 31 426 -32
LimJS,Mietus-SnyderM,ValenteA, 2010.The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome,Nat Rev Gastroenterol Hepatol 7 251 -64